Skip to main content

Table 2 Subgroup analysis of prevalence of GERD

From: Epidemiology of gastroesophageal reflux disease in Iran: a systematic review and meta-analysis

Variable

Studies (N)

Sample (N)

Heterogeneity

95% CI

Pooled prevalence (%)

Total subjects

Event

I2

P-Value

Daily

Areas

Center

6

12,884

680

98.44

<  0.001

2.37–8.47

4.52

East

2

2066

254

98.54

<  0.001

3.21–29.70

10.58

North

2

51,448

5947

98.98

<  0.001

1.09–23.40

5.48

Test for subgroup differences: Q = 1.559, df(Q) = 2, P = 0.459

Population

Blood donors

1

3517

165

–

–

4.05–5.45

4.70

General population

8

59,873

6653

98.18

<  0.001

4.51–9.45

6.56

Health care worker

1

3008

63

–

–

1.64–2.68

2.10

Test for subgroup differences: Q = 38.389, df(Q) = 2, P <  0.001

Year of studies

1991–2004

6

11,691

849

98.65

<  0.001

4.03–13.07

7.37

2005–2013

4

54,707

6032

99.01

<  0.001

1.20–10.51

3.64

Test for subgroup differences: Q = 1.256, df(Q) = 1, P = 0.263

Quality of studies

Low risk

5

55,271

6282

98.52

<  0.001

4.21–12.39

7.31

Moderate risk

5

11,127

600

98.46

<  0.001

2.08–8.54

4.26

Test for subgroup differences: Q = 1.380, df(Q) = 1, P = 0.240

Method of data collection

Questionnaire + Interview

7

61,932

6337

99.06

<  0.001

2.14–7.81

4.12

Interview

3

4466

545

98.91

<  0.001

6.53–18.38

11.14

Test for subgroup differences: Q = 5.488, df(Q) = 1, P = 0.019

Sex

The odds ratio of females to males: 1.503 (95% CI: 1.153–1.59, P = 0.003); Heterogeneity: I2: 68.49%, P = 0.013

Weekly

Areas

Center

9

42,825

4880

99.34

<  0.001

7.92–15.92

11.31

East

2

2066

258

0

0.784

11.15–14.01

12.51

North

4

52,938

4317

91.08

<  0.001

7.04–11.38

8.98

South

4

12,559

2955

97.89

<  0.001

15.22–28.89

21.26

Test for subgroup differences: Q = 17.025, df(Q) = 3, P = 0.001

Population

Blood donors

1

3517

197

–

–

4.89–6.41

5.60

General population

14

98,005

10,770

99.69

<  0.001

10.07–17.91

13.52

Health care worker

4

8866

1443

99.20

<  0.001

5.17–7.39

11.44

Test for subgroup differences: Q = 29.288, df(Q) = 2, P <  0.001

Year of studies

1991–2004

8

14,570

1453

97.25

<  0.001

7.86–13.56

10.37

2005–2013

11

95,818

10,957

99.70

<  0.001

9.95–20.04

14.27

Test for subgroup differences: Q = 1.947, df(Q) = 1, P = 0.163

Quality of studies

Low risk

10

90,079

10,262

99.71

<  0.001

9.85–20.74

14.47

Moderate risk

9

20,309

2149

98.26

<  0.001

7.65–14.46

10.58

Test for subgroup differences: Q = 1.544, df(Q) = 1, P = 0.214

Method of data collection

Interview

3

4466

568

0

0.892

11.77–13.73

12.72

Questionnaire

3

6170

1313

96.95

<  0.001

10.71–25.45

16.83

Questionnaire + Interview

13

99,752

10,529

99.61

<  0.001

8.38–15.92

11.63

Test for subgroup differences: Q = 1.815, df(Q) = 2, P = 0.404

Sex

The odds ratio of females to males: 1.174 (95% CI: 0.974–1.414, P = 0.092); Heterogeneity: I2: 91.63%, P <  0.001

Monthly

Areas

Center

7

17,646

3591

97.55

<  0.001

15.36–22.91

18.84

East

1

1066

161

–

–

13.86–16.42

15.10

North

3

52,037

20,720

99.64

<  0.001

6.22–46.66

19.42

Test for subgroup differences: Q = 3.177, df(Q) = 2, P = 0.204

Population

Blood donors

1

3517

795

98.91

<  0.001

21.25–24.01

22.60

General population

8

63,635

23,110

99.71

<  0.001

12.44–28.62

19.27

Health care worker

2

3597

567

98.23

<  0.001

11.92–18.40

14.87

Test for subgroup differences: Q = 14.531, df(Q) = 2, P = 0.001

Year of studies

1991–2004

6

15,453

3323

95.89

<  0.001

17.14–23.54

20.15

2005–2013

5

55,296

21,149

99.70

<  0.001

7.27–34.71

16.95

Test for subgroup differences: Q = 0.181, df(Q) = 1, P = 0.671

Quality of studies

Low risk

5

55,271

21,159

99.70

<  0.001

7.82–35.92

17.90

Moderate risk

6

15,478

3313

96.03

<  0.001

16.42–22.85

19.43

Test for subgroup differences: Q = 0.042, df(Q) = 1, P = 0.838

Method of data collection

Interview

3

8228

1891

97.45

<  0.001

15.89–26.03

20.50

Questionnaire + Interview

8

62,521

22,581

99.70

<  0.001

10.79–28.45

17.99

Test for subgroup differences: Q = 0.233, df(Q) = 1, P = 0.637

Sex

The odds ratio of females to males: 1.126 (95% CI: 0.849–1.494, P = 0.411); Heterogeneity: I2: 96.68%, P <  0.001

Overall

Areas

Center

6

12,884

4823

97.38

<  0.001

32.01–42.62

37.16

East

1

1066

493

–

–

43.26–49.24

46.24

North

1

49,975

30,415

–

–

60.43–61.26

60.86

South

1

9264

5419

–

–

57.49–59.50

58.50

Test for subgroup differences: Q = 169.751, df(Q) = 3, P <  0.001

Population

Blood donors

1

3517

1157

–

–

31.37–34.47

32.90

General population

7

66,664

38,913

99.43

<  0.001

38.49–53.12

45.71

Health care worker

1

3008

1080

99.09

<  0.001

34.20–37.63

35.90

Test for subgroup differences: Q = 16.155, df(Q) = 2, P <  0.001

Year of studies

1991–2004

5

10,691

4124

97.26

<  0.001

34.36–46.09

40.09

2005–2013

4

62,498

37,026

99.59

<  0.001

37.71–56.28

46.89

Test for subgroup differences: Q = 1.458, df(Q) = 1, P = 0.227

Quality of studies

Low risk

5

63,062

37,471

99.15

<  0.001

43.12–56.23

49.67

Moderate risk

4

10,127

3679

98.20

<  0.001

28.59–42.77

35.36

Test for subgroup differences: Q = 8.008, df(Q) = 1, P = 0.005

Method of data collection

Questionnaire + Interview

7

69,723

39,541

99.73

<  0.001

32.71–52.17

42.14

Interview

2

3466

1609

0

<  0.001

44.76–48.08

46.42

Test for subgroup differences: Q = 0.692, df(Q) = 1, P = 0.406

Sex

The odds ratio of females to males: 1.111 (95% CI: 0.888–1.391, P = 0.358); Heterogeneity: I2: 97.96%, P <  0.001

  1. CI Confidence intervals, N number